Repro India (REPRO)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹324.75 |
| Market Cap | ₹465.86 Cr |
| P/E Ratio | 4.77 |
| ROCE | 1.56% |
| ROE | -6.49% |
| Dividend Yield | 0% |
| Profit Growth | -35.9% |
| Debt/Equity | 0.53 |
| Sales Growth | 20.1% |
| Promoter Holding | 46.71% |
| 52-Week Range | ₹301 — ₹590 |
| Sector | Printing & Publication |
| Book Value | ₹243.72 |
Strengths
- Net profit positive in latest quarter (₹1 Cr) on sales of ₹130 Cr, showing some near-term stability
- Debt/equity ratio of 0.35 is conservative and manageable
- Promoter holding of 46.71% indicates aligned owner interests
- Positive sales growth of 3.43% in a difficult industry
- Book value of ₹253.40 provides a moderate asset floor
Concerns
- Negative ROE of -6.49% and profit decline of -35.90% reflect poor earnings power
- ROCE of only 1.56% is far below any acceptable cost of capital
- Piotroski F-score of 4/9 and FairStock Score of 0/100 signal weak financial health and high risk
- Zero dividend yield means the investor relies entirely on uncertain capital appreciation
AI Analysis
Looking at Repro India, I see a business that fails my first test: does it have a durable competitive advantage? Printing and publication is a challenging industry, facing digital disruption and limited pricing power. The numbers confirm my unease. Return on equity is a negative 6.49%, meaning the company destroyed shareholder value in the past year. Return on capital employed is just 1.56%, far below what I could earn in a risk-free bond. With a Piotroski score of 4 out of 9, the financial health is weak. Sales grew only 3.43%, while profits fell 35.90%. The company trades at ₹354.10, about 1.4 times book value of ₹253.40. That is not a bargain for a business whose earnings power is absent. The price-to-earnings ratio is meaningless when trailing earnings are negative. On the positive side, debt-to-equity of 0.35 is manageable, and promoter holding of 46.71% aligns interests. The latest quarter showed a small net profit of ₹1 Cr on sales of ₹130 Cr, so maybe there's a flicker of improvement. But in Graham's words, 'The investor's chief problem – and even his worst enemy – is likely to be himself.' I would not want to pay a premium for hope. The stock has fallen from its 52-week high of ₹590 to ₹354, but value alone does not make it cheap. I prefer a margin of safety visible in earnings, not just in book value. For now, this is a pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer